Pages

.

Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats

BLUE BELL, Pa., Dec. 19, 2013 /PRNewswire/ -- Security experts at Unisys Corporation (NYSE: UIS) today predicted that the coming year will usher in broad-based adoption of encryption as enterprises respond to recent disclosures that unencrypted data traffic inside enterprises is vulnerable to detection from outsiders.

Disclosures that the U.S. government may have accessed data from the internal networks of major internet service providers have already prompted some of these companies to expand the use of encryption within their own organizations, Unisys experts noted. That activity will continue to grow in 2014, resulting in an explosion in the use of encryption tools, they said.

"Regardless of what you might think of Edward Snowden, the government contractor who leaked secrets about U.S. government surveillance, there is no denying that his disclosures have heightened awareness of cybersecurity all over the world," said Dave Frymier, Unisys chief information security officer. "Before that, many enterprises were running unencrypted data on their internal networks, which they believed were secure. Now they are beginning to use encryption internally as well, so we expect 2014 to be the year of encryption."

As a result of the Snowden disclosures, officials at the highest levels of organizations around the world will increase their focus on data loss prevention, encryption and prioritizing investments in security, Unisys experts predicted.

Frymier added that the increased use of encryption will both enable and encourage more companies to use infrastructure-as-a-service (IaaS) cloud solutions, where previously they might have had concerns about the safety of their data in the cloud.

New iPhone fingerprint readers jumpstart consumer acceptance of biometrics

Unisys experts also predicted that consumers will embrace the accuracy and ease-of-use of fingerprint readers on the new Apple iPhone, leading to a broader acceptance of biometrics in general. This could jump start a rapid growth in the use of biometrics – including fingerprint, iris scanning and facial recognition – on consumer devices as a way to protect the devices and data, as well as a method to confirm the identities of users for activities such as online retail transactions.

The acceptance of biometrics will begin the evolution away from the traditional user ID/password combination used most frequently to verify online identities.

In addition, the ability to automatically pinpoint a user's specific device as well as its geographical location will give security managers insight into the "context" of that user's attempt to access the network. Contextual authentication solutions can alert managers when, for example, someone outside of a pre-determined geographical area attempts to access their networks.

In the same way, attribute-based access controls identify access requests that fall outside a user's normal pattern, such as attempts to obtain information they don't normally access or at unusual hours. By combining these insights with other identity management methods like biometrics, security professionals can make it much more difficult for those without permission to gain access to networks and applications.

Focus on securing mobile devices and apps

Unisys experts predicted a rise in security awareness and protection techniques related to enterprise BYOD (bring your own device) programs. For example, Steve Vinsik, Unisys' vice president for global security solutions, predicted a rise in "bring your own security" scenarios, in which employees using their own mobile devices for work also employ their own security measures – often without the consent or awareness of enterprise security managers.

"That opens up a whole host of issues around how enterprises deal with people having their own security on their devices, and how that interacts with the enterprise's ability to monitor and manage that device," Vinsik said.

Frymier said software sandbox models, in which enterprises deploy mobile apps in an environment that is totally isolated from other applications, will continue to gain acceptance. By employing this model, organizations can stop, start, install and uninstall corporate mobile apps without affecting other parts of the mobile device.

Among financial institutions, advances such as embedded biometrics in mobile devices will give rise to greater acceptance of consumer banking transactions and e-commerce on mobile devices. Likewise, 2014 will see banks further exploring the use of self-service outlets and kiosks that require a combination of physical and digital security methods, including biometrics.

About Unisys

Unisys is a worldwide information technology company. We provide a portfolio of IT services, software, and technology that solves critical problems for clients. We specialize in helping clients secure their operations, increase the efficiency and utilization of their data centers, enhance support to their end users and constituents, and modernize their enterprise applications. To provide these services and solutions, we bring together offerings and capabilities in outsourcing services, systems integration and consulting services, infrastructure services, maintenance services, and high-end server technology. With approximately 22,500 employees, Unisys serves commercial organizations and government agencies throughout the world. For more information, visit www.unisys.com.

Follow Unisys on Twitter.

RELEASE NO.: 1219/9215

Unisys is a registered trademark of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.

SOURCE Unisys Corporation

RELATED LINKS
http://www.unisys.com

reade more... Résuméabuiyad

HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus

HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus. (PRNewsFoto/HGH.us.com)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, Dec. 19, 2013 /PRNewswire-iReach/ -- HGH.us.com, a website that is devoted to providing people with current and factual information about HGH and anti aging, has just announced that it will launch a bi-monthly newsletter that will include information about the latest anti aging therapies. The newsletter will keep the website's loyal readers up-to-date on anti aging HGH supplements, weight loss trends, diets, and current special offers for the various anti aging products.

(Photo: http://photos.prnewswire.com/prnh/20131219/MN36307)

HGH.us.com, which recently celebrated its fifth anniversary, has helped educate thousands of people about the various HGH benefits, HGH side effects, and more. In honor of the website's anniversary, the company would like to share the latest discounts on the Sytropin supplement. For a limited time, people who purchase a 6-month supply of Sytropin will get a discount of $159.75. As it explains in an article on the website, http://hgh.us.com/sytropin.php, the Sytropin company gives customers a 90-day satisfaction guarantee, so anyone who is not fully happy with the product can request a refund.

In addition, HGH.us.com is now offering a great deal on Genf20 Plus; people who buy a 6-month supply will save $199.89, as well as receive free shipping on the supplement for customers who live in the United States, a natural health source $25 discount card, and an infinity health center membership.

As an article on HGH.us.com explains, HGH may be very helpful in slowing down many of the symptoms of aging, such as weight gain, fatigue, memory loss and wrinkles, but still it is not risk free. Some of the side effects of human growth hormone abuse include diabetes, carpal tunnel syndrome, acromegaly and more. For a more detailed article on potential HGH side effects and risks, people can visit http://hgh.us.com/hghsideeffects.php.

Although there are some HGH side effects and risks from injecting the medical version of HGH called Somatropin, those who wish to use HGH only to feel better and lose weight might find that over the counter HGH supplements like Sytropin, Somatropinne, Genf20 Plus or Genfx might just be enough.

"HGH can also help you sleep soundly, improve your sexual performance and drive even boost your energy and endurance," the article noted.

"On top of that you will experience an increase in muscle tone, a loss of body fat and a reduction of wrinkles. These results are incredible and show that HGH actually does work."

Anybody who would like to learn more about HGH is welcome to visit HGH.us.com at any time; there, they can read in-depth information about different anti aging supplements, as well as reviews of the various companies who sell them. Take for instance Genf20 Plus, which can be directly purchased from the Genf20 Plus homepage; the very popular HGH releaser is also reviewed and evaluated at HGH.us.com to both show its positives and negatives.

About HGH.us.com:

HGH.us.com features in-depth and educational articles pertaining to the topic of anti aging. The site, which recently celebrated its fifth anniversary, provides the latest info on how to reverse symptoms of aging, lose weight and how to stay and look healthy. HGH.us.com also features reviews of different anti aging supplements to make it easier for anyone who is interested in giving them a try. For more information on HGH and anti aging, please visit http://hgh.us.com/hgh-supplements.php

Media Contact: Robert White, HGH.us.com, +1 347 571 9268, info@hgh.us.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE HGH.us.com

RELATED LINKS
http://hgh.us.com

reade more... Résuméabuiyad

FacialNetwork.com Announces Beta Release Of "NameTag" The First Real-Time Facial Recognition App For Google Glass

NameTag - Google Glass Facial Recognition Beta App Demonstration.jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";DOWNTOWN LAS VEGAS, Nev., Dec. 19, 2013 /PRNewswire/ -- The real world is about to become a much more connected place. Utilizing some of the most accurate facial recognition software in the world, NameTag can spot a face using Google Glass' camera, send it wirelessly to a server, compare it to millions of records and in seconds return a match complete with a name, additional photos and social media profiles.

FacialNetwork.com, the developer of NameTag, is also currently creating technology to allow the scanning of profile photos from dating sites such as PlentyOfFish.com, OkCupid.com and Match.com. The technology will allow users to scan photos against the more than 450,000 entries in the National Sex Offender Registry and other criminal databases.

"I believe that this will make online dating and offline social interactions much safer and give us a far better understanding of the people around us," said NameTag's creator Kevin Alan Tussy.  "It's much easier to meet interesting new people when we can simply look at someone, see their Facebook, review their LinkedIn page or maybe even see their dating site profile. Often we were interacting with people blindly or not interacting at all. NameTag on Google Glass can change all that."

No longer will social media be limited to the screens of desktops, tablets and smartphones.  With the NameTag app running on Google Glass a user can simply glance at someone nearby and instantly see that person's name, occupation and even visit their Facebook, Instagram or Twitter profiles in real-time.

Tussy explains, "People will soon be able to login to www.NameTag.ws and choose whether or not they want their name and information displayed to others.  It's not about invading anyone's privacy; it's about connecting people that want to be connected. We will even allow users to have one profile that is seen during business hours and another that is only seen in social situations. NameTag can make the big, anonymous world we live in as friendly as a small town."

NameTag is currently available on Glass for Beta testers and expects its website and app to launch in Q1 2014 and hopes it can be officially available to Google Glass users as well.

"Making Real-Time Facial Recognition work on Glass hasn't been easy, but we did it.  Now, the question isn't if we will support Glass; it's will Google support us?" said Tussy.

Google has announced that facial recognition will not yet be supported for Glass; undoubtedly due to pressure from privacy groups but FacialNetwork.com believes that by providing applications with such vast societal benefits, Google will eventually reconsider.

"There will be many providers of augmented reality headsets and even if facial recognition is not supported by some, I'm confident that there will be solutions for such limitations. We are not publishing any information about of our financiers or investors at this time but I will say that we are involved with some very well-respected individuals and Venture Funds," said Tussy.

Demonstration videos can be seen at http://www.youtube.com/watch?v=pVwBXr_nU9Q and http://www.youtube.com/watch?v=pbnqmBqBVIU.

Video with caption: "NameTag - Google Glass Facial Recognition Beta App Demonstration." Video available at: http://www.youtube.com/watch?v=pVwBXr_nU9Q 

Contact: Jordan McGee
jordan@fierrocommunications.com
Office: (702) 385-7300
Cell: (702) 538-6117

SOURCE FacialNetwork.com

reade more... Résuméabuiyad

FacialNetwork.com Announces Beta Release Of "NameTag" The First Real-Time Facial Recognition App For Google Glass

NameTag - Google Glass Facial Recognition Beta App Demonstration.jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";DOWNTOWN LAS VEGAS, Nev., Dec. 19, 2013 /PRNewswire/ -- The real world is about to become a much more connected place. Utilizing some of the most accurate facial recognition software in the world, NameTag can spot a face using Google Glass' camera, send it wirelessly to a server, compare it to millions of records and in seconds return a match complete with a name, additional photos and social media profiles.

FacialNetwork.com, the developer of NameTag, is also currently creating technology to allow the scanning of profile photos from dating sites such as PlentyOfFish.com, OkCupid.com and Match.com. The technology will allow users to scan photos against the more than 450,000 entries in the National Sex Offender Registry and other criminal databases.

"I believe that this will make online dating and offline social interactions much safer and give us a far better understanding of the people around us," said NameTag's creator Kevin Alan Tussy.  "It's much easier to meet interesting new people when we can simply look at someone, see their Facebook, review their LinkedIn page or maybe even see their dating site profile. Often we were interacting with people blindly or not interacting at all. NameTag on Google Glass can change all that."

No longer will social media be limited to the screens of desktops, tablets and smartphones.  With the NameTag app running on Google Glass a user can simply glance at someone nearby and instantly see that person's name, occupation and even visit their Facebook, Instagram or Twitter profiles in real-time.

Tussy explains, "People will soon be able to login to www.NameTag.ws and choose whether or not they want their name and information displayed to others.  It's not about invading anyone's privacy; it's about connecting people that want to be connected. We will even allow users to have one profile that is seen during business hours and another that is only seen in social situations. NameTag can make the big, anonymous world we live in as friendly as a small town."

NameTag is currently available on Glass for Beta testers and expects its website and app to launch in Q1 2014 and hopes it can be officially available to Google Glass users as well.

"Making Real-Time Facial Recognition work on Glass hasn't been easy, but we did it.  Now, the question isn't if we will support Glass; it's will Google support us?" said Tussy.

Google has announced that facial recognition will not yet be supported for Glass; undoubtedly due to pressure from privacy groups but FacialNetwork.com believes that by providing applications with such vast societal benefits, Google will eventually reconsider.

"There will be many providers of augmented reality headsets and even if facial recognition is not supported by some, I'm confident that there will be solutions for such limitations. We are not publishing any information about of our financiers or investors at this time but I will say that we are involved with some very well-respected individuals and Venture Funds," said Tussy.

Demonstration videos can be seen at http://www.youtube.com/watch?v=pVwBXr_nU9Q and http://www.youtube.com/watch?v=pbnqmBqBVIU.

Video with caption: "NameTag - Google Glass Facial Recognition Beta App Demonstration." Video available at: http://www.youtube.com/watch?v=pVwBXr_nU9Q 

Contact: Jordan McGee
jordan@fierrocommunications.com
Office: (702) 385-7300
Cell: (702) 538-6117

SOURCE FacialNetwork.com

reade more... Résuméabuiyad

Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats

BLUE BELL, Pa., Dec. 19, 2013 /PRNewswire/ -- Security experts at Unisys Corporation (NYSE: UIS) today predicted that the coming year will usher in broad-based adoption of encryption as enterprises respond to recent disclosures that unencrypted data traffic inside enterprises is vulnerable to detection from outsiders.

Disclosures that the U.S. government may have accessed data from the internal networks of major internet service providers have already prompted some of these companies to expand the use of encryption within their own organizations, Unisys experts noted. That activity will continue to grow in 2014, resulting in an explosion in the use of encryption tools, they said.

"Regardless of what you might think of Edward Snowden, the government contractor who leaked secrets about U.S. government surveillance, there is no denying that his disclosures have heightened awareness of cybersecurity all over the world," said Dave Frymier, Unisys chief information security officer. "Before that, many enterprises were running unencrypted data on their internal networks, which they believed were secure. Now they are beginning to use encryption internally as well, so we expect 2014 to be the year of encryption."

As a result of the Snowden disclosures, officials at the highest levels of organizations around the world will increase their focus on data loss prevention, encryption and prioritizing investments in security, Unisys experts predicted.

Frymier added that the increased use of encryption will both enable and encourage more companies to use infrastructure-as-a-service (IaaS) cloud solutions, where previously they might have had concerns about the safety of their data in the cloud.

New iPhone fingerprint readers jumpstart consumer acceptance of biometrics

Unisys experts also predicted that consumers will embrace the accuracy and ease-of-use of fingerprint readers on the new Apple iPhone, leading to a broader acceptance of biometrics in general. This could jump start a rapid growth in the use of biometrics – including fingerprint, iris scanning and facial recognition – on consumer devices as a way to protect the devices and data, as well as a method to confirm the identities of users for activities such as online retail transactions.

The acceptance of biometrics will begin the evolution away from the traditional user ID/password combination used most frequently to verify online identities.

In addition, the ability to automatically pinpoint a user's specific device as well as its geographical location will give security managers insight into the "context" of that user's attempt to access the network. Contextual authentication solutions can alert managers when, for example, someone outside of a pre-determined geographical area attempts to access their networks.

In the same way, attribute-based access controls identify access requests that fall outside a user's normal pattern, such as attempts to obtain information they don't normally access or at unusual hours. By combining these insights with other identity management methods like biometrics, security professionals can make it much more difficult for those without permission to gain access to networks and applications.

Focus on securing mobile devices and apps

Unisys experts predicted a rise in security awareness and protection techniques related to enterprise BYOD (bring your own device) programs. For example, Steve Vinsik, Unisys' vice president for global security solutions, predicted a rise in "bring your own security" scenarios, in which employees using their own mobile devices for work also employ their own security measures – often without the consent or awareness of enterprise security managers.

"That opens up a whole host of issues around how enterprises deal with people having their own security on their devices, and how that interacts with the enterprise's ability to monitor and manage that device," Vinsik said.

Frymier said software sandbox models, in which enterprises deploy mobile apps in an environment that is totally isolated from other applications, will continue to gain acceptance. By employing this model, organizations can stop, start, install and uninstall corporate mobile apps without affecting other parts of the mobile device.

Among financial institutions, advances such as embedded biometrics in mobile devices will give rise to greater acceptance of consumer banking transactions and e-commerce on mobile devices. Likewise, 2014 will see banks further exploring the use of self-service outlets and kiosks that require a combination of physical and digital security methods, including biometrics.

About Unisys

Unisys is a worldwide information technology company. We provide a portfolio of IT services, software, and technology that solves critical problems for clients. We specialize in helping clients secure their operations, increase the efficiency and utilization of their data centers, enhance support to their end users and constituents, and modernize their enterprise applications. To provide these services and solutions, we bring together offerings and capabilities in outsourcing services, systems integration and consulting services, infrastructure services, maintenance services, and high-end server technology. With approximately 22,500 employees, Unisys serves commercial organizations and government agencies throughout the world. For more information, visit www.unisys.com.

Follow Unisys on Twitter.

RELEASE NO.: 1219/9215

Unisys is a registered trademark of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.

SOURCE Unisys Corporation

RELATED LINKS
http://www.unisys.com

reade more... Résuméabuiyad

HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus

HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus. (PRNewsFoto/HGH.us.com)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, Dec. 19, 2013 /PRNewswire-iReach/ -- HGH.us.com, a website that is devoted to providing people with current and factual information about HGH and anti aging, has just announced that it will launch a bi-monthly newsletter that will include information about the latest anti aging therapies. The newsletter will keep the website's loyal readers up-to-date on anti aging HGH supplements, weight loss trends, diets, and current special offers for the various anti aging products.

(Photo: http://photos.prnewswire.com/prnh/20131219/MN36307)

HGH.us.com, which recently celebrated its fifth anniversary, has helped educate thousands of people about the various HGH benefits, HGH side effects, and more. In honor of the website's anniversary, the company would like to share the latest discounts on the Sytropin supplement. For a limited time, people who purchase a 6-month supply of Sytropin will get a discount of $159.75. As it explains in an article on the website, http://hgh.us.com/sytropin.php, the Sytropin company gives customers a 90-day satisfaction guarantee, so anyone who is not fully happy with the product can request a refund.

In addition, HGH.us.com is now offering a great deal on Genf20 Plus; people who buy a 6-month supply will save $199.89, as well as receive free shipping on the supplement for customers who live in the United States, a natural health source $25 discount card, and an infinity health center membership.

As an article on HGH.us.com explains, HGH may be very helpful in slowing down many of the symptoms of aging, such as weight gain, fatigue, memory loss and wrinkles, but still it is not risk free. Some of the side effects of human growth hormone abuse include diabetes, carpal tunnel syndrome, acromegaly and more. For a more detailed article on potential HGH side effects and risks, people can visit http://hgh.us.com/hghsideeffects.php.

Although there are some HGH side effects and risks from injecting the medical version of HGH called Somatropin, those who wish to use HGH only to feel better and lose weight might find that over the counter HGH supplements like Sytropin, Somatropinne, Genf20 Plus or Genfx might just be enough.

"HGH can also help you sleep soundly, improve your sexual performance and drive even boost your energy and endurance," the article noted.

"On top of that you will experience an increase in muscle tone, a loss of body fat and a reduction of wrinkles. These results are incredible and show that HGH actually does work."

Anybody who would like to learn more about HGH is welcome to visit HGH.us.com at any time; there, they can read in-depth information about different anti aging supplements, as well as reviews of the various companies who sell them. Take for instance Genf20 Plus, which can be directly purchased from the Genf20 Plus homepage; the very popular HGH releaser is also reviewed and evaluated at HGH.us.com to both show its positives and negatives.

About HGH.us.com:

HGH.us.com features in-depth and educational articles pertaining to the topic of anti aging. The site, which recently celebrated its fifth anniversary, provides the latest info on how to reverse symptoms of aging, lose weight and how to stay and look healthy. HGH.us.com also features reviews of different anti aging supplements to make it easier for anyone who is interested in giving them a try. For more information on HGH and anti aging, please visit http://hgh.us.com/hgh-supplements.php

Media Contact: Robert White, HGH.us.com, +1 347 571 9268, info@hgh.us.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE HGH.us.com

RELATED LINKS
http://hgh.us.com

reade more... Résuméabuiyad

Business Analyst Training Chennai (Bhargavi Adaptive)

Business analysis is a critical process that drives the project life cycle. The business analyst, acting as an intermediary between the business and technical communities, analyzes competing business needs and develops plans to implement the projects that support stakeholder objectives. In this course, you gain foundational knowledge of the role and function of the business analyst. You also learn to apply a clearly defined business analysis framework.
Course Highlights and Key Take Away
* 100% success rate for CBAP and CCBA certification past record
* Question Bank with 450 IIBA model questions for all participants
* Adaptive Processes Consulting (www.adaptiveprocesses.com) is an Endorsed Education Provider of IIBA, see the listing here http://tinyurl.com/IIBA-Adaptive-EEP
* Complimentary e-learning on Business Analysis skills based on BABOK to all participants
* Pre class reading material on BA tools to all participants
* Hard copy Course material to all participants based on BABOK 2.0
* CBAP/CCBA Preparation help and guidance by experienced CBAP certified faculty
* Case study based approach
* Complimentary business analysis toolkit for all participants for the session
* We cover all essential BA tools and techniques like UML, BPM, Test Automation Tools, Requirement Elicitation
* IIBA Endorsed program - You get 21 contact hours for CBAP/CCBA certification by IIBA
* Faculty with more than decade long experience in business analysis and software project management, product development experience - Faculty is CBAP and an industry expert with lot of subject matter experience and is well known in the industry
* Excellent participant feedback (http:// tinyurl.com/Linkedin-BA-feedback, http:// tinyurl.com/BA-feedback,http://www.adaptiveprocesses.com/Training-Feedback.html)
* Complimentary CBAP model questions for all participants
* The course also prepare the candidates for the CBAP certification with Mock test and preparation with sample questions.
* We provide sample templates, policies and artifacts from our tool kit which helps people in implementation of the concepts in their job.
* The program covers BA tools and techniques like UML, BPM, Requirements elicitation, Stakeholder Management, Solution Assessment and Elicitation Techniques etc.
* Certified PMP? recipients can claim 21 PDUs for their CDU requirements by attending this workshop.
Target Audience: Business Analysts, Software Analysts, Functional Analysts, Market Analyst, Project Managers, Software Architects, Senior Programmers, Transition Analysts, Transition Managers, Transition Leads.

Course Content:
Day 1, Day2 and Day 3:
* e-learning on BA Concepts based on BABOK 2.0
* BA tools learning based on pre class study material on BA tools
Day 4:
* Participant and faculty introduction
* Introduction to business analysis
* Business Analyst responsibilities and skills
* Analytical thinking and problem solving
* Exercise on problem solving Communication skill
* Negotiation Skills
* Business Analysis Process

* Exercise on negotiation skills
* Managing Business Change
* Discussion on BA tools
* Business analysis process
* Stakeholder Management
* Case study on stakeholder management
Day 5:
* Remaining parts of business analysis process
* Exercise on BA planning
* Enterprise Analysis
* Process mapping tools
* Process mapping exercise
* Remaining parts of enterprise analysis
* Elicitation Techniques
* Requirements analysis
* Solution assessment
* Requirements management
* Exercise on Elicitation Techniques
* Exercise on requirements analysis
* Requirements management
* Solution assessment
Day 6:
* IT System Modeling
* Use case modeling
* Testing Principles
* Test automation tools
* Case study on development of test cases
* CBAP preparation tips
* CBAP mock test and answer discussion
* Question and answers
* Feedback and closure
Faculty Profile:
* Senior Consultant and Trainer
* CBAP from IIBA, Canada
* Worked as business analyst with Cap Gemini, Sigma Software and IndoGlobal
* Proven expertise in Business analysis activities for projects in Finance (Wealth Management), Telecom (Voice, Video, Data Service Provisioning and Activation), Process Automation, and Life Sciences domains.
* Business Analysis consultant to various clients and projects helping them choose right business analysis approach.
* Conducted multiple public and in-house workshops conducted in the areas of Business analysis and Requirements Analysis with excellent participant feedback.
* 7+ years of industry experience in software development and business analysis
* Post Graduate Diploma in Marketing Management, Marketing
* Bachelor in Engineering in Information Technology, University of Pune
Course Designer Profile:
CBAP, PMP, CSM, Six Sigma Black Belt, Certified ISO 9001, ISO 20000 and 27001 Lead Auditor, CSQA (World Topper for the year 2000), PGDM (IIMA) and BE.

18+ years of professional experience in business analysis, project management, product development and consulting. He has consulted several large clients in US, Europe and India for IBM, Infosys, PWC, iGate, MACH, Ness Technologies, AXA Group Solutions etc. He has played role of business analyst for multiple projects in implementing large ERPs and developing software products.

All our Faculties come with more than decade long experience in business analysis, software project management and product development experience.

All the faculties are CBAP certified professional.

Program Feedback:
Please find the earlier program feedback under the following link:
http://tinyurl.com/Linkedin-BA-feedback
http://tinyurl.com/BA-feedback
http://www.adaptiveprocesses.com/Training-Feedback.html

BA workshop FAQ:

http://www.adaptiveprocesses.com/faq/BusinessAnalystTrainingFAQ.pdf
Registration/Clarifications:
Please contact:
Ananya M:+91 9343794800/9019450325

Processing ...
reade more... Résuméabuiyad

Advantages of on-site courses (Safi Qudsi)

Training is important. Getting trained properly is more important. Three different kinds of training available. The two most well-known kinds of training are classroom training and on-site training course. One is where the instructor and the students will be in a room where the training will be conducted; basically it will be theory and bookish knowledge. While the other, is on-site Coaching, where the candidate will get trained in the office or company premises. This is one of the perfect ways of training and people who attend such Coaching do have certain best benefits or advantages.

The foremost advantage of on-site training is convenience. Time management is done aptly and lost time is kept to a minimum. On-site courses are very cost effective. Travelling to any other place is negative and so is the travel expense. The trainee does not have to worry about boarding and lodging too. The trainee would need to go to the regular place of employment and the course or the Coaching will be held there. This is one way by which all the extra expenditure is almost nil, this way both the employer and the employee get benefited from this arrangement of on-site training courses.

The next benefit can be seen as course tailoring. Each and every subject has its own depth and is very vast to cover. If the Coaching is done in the specific office, on-site courses can be designed to address the specific need of the organization. Proper specification and tailoring of the course can eliminate unnecessary time spent on learning things which are not required or is of no use for the current training which is ongoing at work place. On-site courses always help the organization meet the specific requirement of the organization without any difficulties.

Such courses give flexibility in terms of the variety of courses available. If you are comfortable with a particular trainer then you can attend the very same classes and build a good rapport with the trainer. This way you will gain more confidence and will be able to grasp the subject more easily and the knowledge will be shared extremely well between the trainer and the trainee. A large organization may have different branches spread across the world. On-site course will help the trainee learn things at the same level and manner with the employees of the other branches because identical training will be provided to everyone.


As the employees undergo Coaching in the office premises it proves to be advantageous. There is no extra time taken and the training is held just for a specific time period during the day. If there is any need for the employee to come back to the department urgently, in such cases the staff can be contacted immediately and the issue or problem can be resolved quickly. Everyone gets the same kind of training. There is no difference in the training method. This kind of training is always beneficial and will give good results to the organization or company.

In most circumstances, on-site courses are preferred because it is cost effective and practical. The kind of facilities available in the organization and its size should be considered before opting for on-site course. The Coaching budget should also be well-thought-out. The need to control expenses, customized training method, time management, convenient, quick access of employees and increased competition will make on-site courses more popular in the future. All the big organizations and companies will opt for this then sending their employees out of the city to get trained or to attend training for a subject in some institute.

To get more details on the same call us At (281-804-8632) or log on to our website http://www.aqss-usa.com/our-company.asp

AQSS is a Houston based company, with a team of highly experienced and certified/qualified auditors Learn more at Onsite course
reade more... Résuméabuiyad

Benefits from training is tremendous (Safi Qudsi)

It is a well-known and popular subject - training. There are career build in training. People want to become trainers and train others in a particular subject. There are programs which help individuals to become qualified and well experienced trainers. The subject training is vast and has different roles that one can play with it. One of the other best parts is getting trained in a particular subject and excelling in it. This proves to be advantageous for the candidate who has opted to get trained. It opens new door and opportunities for him or her.

Expediting services are one of the most important things when it comes to purchasing or project management. Especially when it comes to large scale projects like constructing of refineries or power plants these services come into play. People having training in expediting services is considered over others. These people make sure that the goods supplied to erect the project are of quality, delivered on time, make sure that there is no extra cost, minimize potential risk and make sure that the client is happy with the work done for them.

Companies who are into constructions use this service. This service makes sure that the clients are happy and the project completes successfully with no loss of materials, life or any kind of eventuality. The training in expediting services makes the specialist work as per guidelines and he or she knows what to check for in the material supplied and how to bargain and get a cost which is beneficial for the company and the supplier.

Any kind of training makes sure that the person is extremely well versed in the subject, is confident to handle any situation and to take the best decision for the company that he or she work for. The skill imparted during training is a boon to the individual and he or she will have it as an asset for the lifetime. No one can take it away from them and they can catch on it extremely well. Going by the books is good but having a practical insight is an added advantage. Training comprises of both. One gets bookish knowledge as well as practical experience in doing a particular thing. Professional training is very in depth and needs lot of time and patience to finish it properly with good score. If a company is giving the training then they will definitely see how you have fared in the training based on which you might get promoted or go to the next level without any hitches.


All of us can benefit from training and we should take it up enthusiastically. At the same time the trainers should make sure that the training sessions are not boring and it should involve all the students and the class should be vibrant with exchange of ideas and making sure that each and everyone in the room has understood the subject well and there is no scope of any confusion. All of this can be done by a qualified and experienced instructor. It is not easy to train experienced individuals who have worked in different companies and are still working. Getting them on the same level and making them go through the strenuous basic ritual with no complaints is not an easy job. And only and experienced trainer can do it and get the best out of his or her students. To sum it up, in a strong note, we can say that training is one of the important things in life and one should never ignore it and enjoy its benefits.

To get more details on the same call us At (281-804-8632) or log on to our website http://www.aqss-usa.com/expediting-services.asp

AQSS is a Houston based company, with a team of highly experienced and certified/qualified auditors Learn more at Expediting Services
reade more... Résuméabuiyad

FacialNetwork.com Announces Beta Release Of "NameTag" The First Real-Time Facial Recognition App For Google Glass

NameTag - Google Glass Facial Recognition Beta App Demonstration.jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";DOWNTOWN LAS VEGAS, Nev., Dec. 19, 2013 /PRNewswire/ -- The real world is about to become a much more connected place. Utilizing some of the most accurate facial recognition software in the world, NameTag can spot a face using Google Glass' camera, send it wirelessly to a server, compare it to millions of records and in seconds return a match complete with a name, additional photos and social media profiles.

FacialNetwork.com, the developer of NameTag, is also currently creating technology to allow the scanning of profile photos from dating sites such as PlentyOfFish.com, OkCupid.com and Match.com. The technology will allow users to scan photos against the more than 450,000 entries in the National Sex Offender Registry and other criminal databases.

"I believe that this will make online dating and offline social interactions much safer and give us a far better understanding of the people around us," said NameTag's creator Kevin Alan Tussy.  "It's much easier to meet interesting new people when we can simply look at someone, see their Facebook, review their LinkedIn page or maybe even see their dating site profile. Often we were interacting with people blindly or not interacting at all. NameTag on Google Glass can change all that."

No longer will social media be limited to the screens of desktops, tablets and smartphones.  With the NameTag app running on Google Glass a user can simply glance at someone nearby and instantly see that person's name, occupation and even visit their Facebook, Instagram or Twitter profiles in real-time.

Tussy explains, "People will soon be able to login to www.NameTag.ws and choose whether or not they want their name and information displayed to others.  It's not about invading anyone's privacy; it's about connecting people that want to be connected. We will even allow users to have one profile that is seen during business hours and another that is only seen in social situations. NameTag can make the big, anonymous world we live in as friendly as a small town."

NameTag is currently available on Glass for Beta testers and expects its website and app to launch in Q1 2014 and hopes it can be officially available to Google Glass users as well.

"Making Real-Time Facial Recognition work on Glass hasn't been easy, but we did it.  Now, the question isn't if we will support Glass; it's will Google support us?" said Tussy.

Google has announced that facial recognition will not yet be supported for Glass; undoubtedly due to pressure from privacy groups but FacialNetwork.com believes that by providing applications with such vast societal benefits, Google will eventually reconsider.

"There will be many providers of augmented reality headsets and even if facial recognition is not supported by some, I'm confident that there will be solutions for such limitations. We are not publishing any information about of our financiers or investors at this time but I will say that we are involved with some very well-respected individuals and Venture Funds," said Tussy.

Demonstration videos can be seen at http://www.youtube.com/watch?v=pVwBXr_nU9Q and http://www.youtube.com/watch?v=pbnqmBqBVIU.

Video with caption: "NameTag - Google Glass Facial Recognition Beta App Demonstration." Video available at: http://www.youtube.com/watch?v=pVwBXr_nU9Q 

Contact: Jordan McGee
jordan@fierrocommunications.com
Office: (702) 385-7300
Cell: (702) 538-6117

SOURCE FacialNetwork.com

reade more... Résuméabuiyad

HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus

HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus. (PRNewsFoto/HGH.us.com)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, Dec. 19, 2013 /PRNewswire-iReach/ -- HGH.us.com, a website that is devoted to providing people with current and factual information about HGH and anti aging, has just announced that it will launch a bi-monthly newsletter that will include information about the latest anti aging therapies. The newsletter will keep the website's loyal readers up-to-date on anti aging HGH supplements, weight loss trends, diets, and current special offers for the various anti aging products.

(Photo: http://photos.prnewswire.com/prnh/20131219/MN36307)

HGH.us.com, which recently celebrated its fifth anniversary, has helped educate thousands of people about the various HGH benefits, HGH side effects, and more. In honor of the website's anniversary, the company would like to share the latest discounts on the Sytropin supplement. For a limited time, people who purchase a 6-month supply of Sytropin will get a discount of $159.75. As it explains in an article on the website, http://hgh.us.com/sytropin.php, the Sytropin company gives customers a 90-day satisfaction guarantee, so anyone who is not fully happy with the product can request a refund.

In addition, HGH.us.com is now offering a great deal on Genf20 Plus; people who buy a 6-month supply will save $199.89, as well as receive free shipping on the supplement for customers who live in the United States, a natural health source $25 discount card, and an infinity health center membership.

As an article on HGH.us.com explains, HGH may be very helpful in slowing down many of the symptoms of aging, such as weight gain, fatigue, memory loss and wrinkles, but still it is not risk free. Some of the side effects of human growth hormone abuse include diabetes, carpal tunnel syndrome, acromegaly and more. For a more detailed article on potential HGH side effects and risks, people can visit http://hgh.us.com/hghsideeffects.php.

Although there are some HGH side effects and risks from injecting the medical version of HGH called Somatropin, those who wish to use HGH only to feel better and lose weight might find that over the counter HGH supplements like Sytropin, Somatropinne, Genf20 Plus or Genfx might just be enough.

"HGH can also help you sleep soundly, improve your sexual performance and drive even boost your energy and endurance," the article noted.

"On top of that you will experience an increase in muscle tone, a loss of body fat and a reduction of wrinkles. These results are incredible and show that HGH actually does work."

Anybody who would like to learn more about HGH is welcome to visit HGH.us.com at any time; there, they can read in-depth information about different anti aging supplements, as well as reviews of the various companies who sell them. Take for instance Genf20 Plus, which can be directly purchased from the Genf20 Plus homepage; the very popular HGH releaser is also reviewed and evaluated at HGH.us.com to both show its positives and negatives.

About HGH.us.com:

HGH.us.com features in-depth and educational articles pertaining to the topic of anti aging. The site, which recently celebrated its fifth anniversary, provides the latest info on how to reverse symptoms of aging, lose weight and how to stay and look healthy. HGH.us.com also features reviews of different anti aging supplements to make it easier for anyone who is interested in giving them a try. For more information on HGH and anti aging, please visit http://hgh.us.com/hgh-supplements.php

Media Contact: Robert White, HGH.us.com, +1 347 571 9268, info@hgh.us.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE HGH.us.com

RELATED LINKS
http://hgh.us.com

reade more... Résuméabuiyad

Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats

BLUE BELL, Pa., Dec. 19, 2013 /PRNewswire/ -- Security experts at Unisys Corporation (NYSE: UIS) today predicted that the coming year will usher in broad-based adoption of encryption as enterprises respond to recent disclosures that unencrypted data traffic inside enterprises is vulnerable to detection from outsiders.

Disclosures that the U.S. government may have accessed data from the internal networks of major internet service providers have already prompted some of these companies to expand the use of encryption within their own organizations, Unisys experts noted. That activity will continue to grow in 2014, resulting in an explosion in the use of encryption tools, they said.

"Regardless of what you might think of Edward Snowden, the government contractor who leaked secrets about U.S. government surveillance, there is no denying that his disclosures have heightened awareness of cybersecurity all over the world," said Dave Frymier, Unisys chief information security officer. "Before that, many enterprises were running unencrypted data on their internal networks, which they believed were secure. Now they are beginning to use encryption internally as well, so we expect 2014 to be the year of encryption."

As a result of the Snowden disclosures, officials at the highest levels of organizations around the world will increase their focus on data loss prevention, encryption and prioritizing investments in security, Unisys experts predicted.

Frymier added that the increased use of encryption will both enable and encourage more companies to use infrastructure-as-a-service (IaaS) cloud solutions, where previously they might have had concerns about the safety of their data in the cloud.

New iPhone fingerprint readers jumpstart consumer acceptance of biometrics

Unisys experts also predicted that consumers will embrace the accuracy and ease-of-use of fingerprint readers on the new Apple iPhone, leading to a broader acceptance of biometrics in general. This could jump start a rapid growth in the use of biometrics – including fingerprint, iris scanning and facial recognition – on consumer devices as a way to protect the devices and data, as well as a method to confirm the identities of users for activities such as online retail transactions.

The acceptance of biometrics will begin the evolution away from the traditional user ID/password combination used most frequently to verify online identities.

In addition, the ability to automatically pinpoint a user's specific device as well as its geographical location will give security managers insight into the "context" of that user's attempt to access the network. Contextual authentication solutions can alert managers when, for example, someone outside of a pre-determined geographical area attempts to access their networks.

In the same way, attribute-based access controls identify access requests that fall outside a user's normal pattern, such as attempts to obtain information they don't normally access or at unusual hours. By combining these insights with other identity management methods like biometrics, security professionals can make it much more difficult for those without permission to gain access to networks and applications.

Focus on securing mobile devices and apps

Unisys experts predicted a rise in security awareness and protection techniques related to enterprise BYOD (bring your own device) programs. For example, Steve Vinsik, Unisys' vice president for global security solutions, predicted a rise in "bring your own security" scenarios, in which employees using their own mobile devices for work also employ their own security measures – often without the consent or awareness of enterprise security managers.

"That opens up a whole host of issues around how enterprises deal with people having their own security on their devices, and how that interacts with the enterprise's ability to monitor and manage that device," Vinsik said.

Frymier said software sandbox models, in which enterprises deploy mobile apps in an environment that is totally isolated from other applications, will continue to gain acceptance. By employing this model, organizations can stop, start, install and uninstall corporate mobile apps without affecting other parts of the mobile device.

Among financial institutions, advances such as embedded biometrics in mobile devices will give rise to greater acceptance of consumer banking transactions and e-commerce on mobile devices. Likewise, 2014 will see banks further exploring the use of self-service outlets and kiosks that require a combination of physical and digital security methods, including biometrics.

About Unisys

Unisys is a worldwide information technology company. We provide a portfolio of IT services, software, and technology that solves critical problems for clients. We specialize in helping clients secure their operations, increase the efficiency and utilization of their data centers, enhance support to their end users and constituents, and modernize their enterprise applications. To provide these services and solutions, we bring together offerings and capabilities in outsourcing services, systems integration and consulting services, infrastructure services, maintenance services, and high-end server technology. With approximately 22,500 employees, Unisys serves commercial organizations and government agencies throughout the world. For more information, visit www.unisys.com.

Follow Unisys on Twitter.

RELEASE NO.: 1219/9215

Unisys is a registered trademark of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.

SOURCE Unisys Corporation

RELATED LINKS
http://www.unisys.com

reade more... Résuméabuiyad

State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption

MOUNTAIN VIEW, Calif., Dec. 18, 2013 /PRNewswire/ -- Tissue engineering is a rapidly diversifying technology that emerged as a regenerative or reparative medicine with potential to circumvent organ shortage globally. Extensive developments in tissue engineering, which involve leveraging technologies from biomaterials, molecular medicine, biochemistry, nanotechnology, genetic, and biomedical engineering, target the restructure and/or repair of human organs through regeneration and cell expansion.

In recent years, cell-based technologies and the integration of genetics – with the use of biological substitutes that aim to restore, maintain or enhance tissue function – have been a popular approach for tissue regeneration and reparation treatment, according to Frost & Sullivan's Advances in Tissue Engineering and Organ Regeneration: Technology Market Penetration and Roadmapping analysis (http://www.technicalinsights.frost.com).

For more information on this research, please email Jennifer Carson, Corporate Communications, at jennifer.carson@frost.com.

Tissue engineering has been a field marked by extensive research and development (R&D), and companies take several years to commercially launch products.

"Still considered a nascent science, research in the field has offered and continues to offer an increasing number of substitutes for applications that would enable the human body to withstand pain and injuries," said Frost & Sullivan Technical Insights Industry Analyst Darshana De. "Apart from previous applications such as the common regeneration of bone, cartilage and skin, current targets have expanded to cardiovascular, kidney, pancreas, liver, spine, ligament, esophagus, cornea, thoracic, lung, nerve, lymphatic and blood vessels."

Despite this expanding capability and the technology's remarkable impact on the healthcare sector, tissue engineers need to overcome many challenges for their field to gain recognition as a mainstream medical technology. For instance, safety and efficacy remain top concerns with several products still undergoing research studies for their validation. Therefore, most patients continue to opt for treatment by medication and the usage of medical devices for temporary relief of symptoms.

Nevertheless, regenerative medicine has immense scope as a disruptive technology, especially as a number of medical device and pharmaceutical companies are conducting R&D through mergers and acquisitions with smaller companies or partnerships with the academic sector.

"As a result, stem cells and cell transplantation technology have evolved from a lab-based research hypothesis model into an applicable treatment mode for patients," observed De. "Recent advancements in molecular biology tools, imaging equipment, and cellular mechanism elucidation could provide more discoveries, substantiation, and an improved R&D process for cell-based therapies."

The convergence of these methodologies and equipment will open up new opportunities for different stakeholders and quicken market penetration.

Advances in Tissue Engineering and Organ Regeneration: Technology Market Penetration and Roadmapping, a part of the Technical Insights subscription, details the advancements in tissue engineering technology and provides an overview of the value chain networks existing in this domain. The study analyzes the market impact of innovations in tissue engineering and organ regeneration, key business accelerators and challenges, and end-user demand. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.

Connect with us on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation. The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Advances in Tissue Engineering and Organ Regeneration: Technology Market Penetration and Roadmapping
D506-TI

Contact:
Jennifer Carson
Corporate Communications – North America
P: 210.247.2450
E: jennifer.carson@frost.com

LinkedIn: Transform Health Group
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com
http://www.technicalinsights.frost.com

SOURCE Frost & Sullivan

RELATED LINKS
http://www.frost.com

reade more... Résuméabuiyad

Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders

CORAL SPRINGS, Florida, December 18, 2013 /PRNewswire/ --

Tech leaders close out 2013 with beneficial internal moves and acquisitions: NXT-ID, Inc. (OTCQB: NXTD), Symantec Corporation (NASDAQ: SYMC), Avago Technologies Limited (NASDAQ: AVGO), Nuance Communications, Inc. (NASDAQ: NUAN) and Apple Inc. (NASDAQ: AAPL)

NXT-ID, Inc. (OTCQB:NXTD) Headline News:  NXT-ID Appoints Two Former MasterCard Executives to Its Newly Formed Advisory Board And Shows First Images of the Biometrically Secure Wallet, The Wocket(TM).  NXT-ID, a biometrics company focused on the growing m-commerce market, announces the appointment of two key advisory board members, Mr. Lawrence Flanagan and Mr. Ken Moy. The appointments from the card payment industry align with the company's roll-out and 2014 launch of The Wocket™, a next generation biometrically secure wallet.  "We are honored and excited to have two luminaries of the card payment world on our advisory board," said Gino Pereira, CEO of NXT-ID, Inc. "Their experience is invaluable to our future prospects and growth for The Wocket™. We look forward to growing our advisory board over the next few months with equally talented and experienced individuals."

To read the full press release and get more information & specific details regarding Mr. Flanagan and Mr. Moy, please click here: http://finance.yahoo.com/news/nxt-id-appoints-two-former-130155944.html 

NXT-ID, Inc. also released the first images of The Wocket(TM) on its corporate website and product website late last week.  About The Wocket(TM) - The Wocket(TM) is a next generation designed to replace all the cards in your wallet without draining your cell phone's battery; no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://thewocket.com/

Symantec Corporation (NASDAQ: SYMC) has announced the recipients of the 2013 Symantec Research Labs Graduate Fellowship -- Kai Ren, a Ph.D. candidate in computer science at Carnegie Mellon University, and Christian Rossow, a postdoctoral researcher at Vrije Universiteit Amsterdam in The Netherlands and Ruhr University Bochum in Germany. Symantec Research Labs is the Company's global research division and has developed and helped commercialize numerous next-generation technologies ranging from Symantec's first antispam technology, to the technology used to help protect our nation's critical power-grid infrastructure. The Symantec Research Labs Graduate Fellowship supports graduate students who are conducting innovative research that has real-world value, in the areas of information security and storage systems.  

Avago Technologies Limited (NASDAQ: AVGO) and LSI Corporation (NASDAQ: LSI) recently announced that they have entered into a definitive agreement under which Avago will acquire LSI for $11.15 per share in an all-cash transaction valued at $6.6 billion. The acquisition creates a highly diversified semiconductor market leader with approximately $5 billion in annual revenues by adding enterprise storage to Avago's existing wired infrastructure, wireless and industrial businesses. The combined company will be strongly positioned to capitalize on the growing opportunities created by the rapid increases in data center IP and mobile data traffic. "This highly complementary and compelling acquisition positions Avago as a leader in the enterprise storage market and expands our offerings and capabilities in wired infrastructure, particularly system-level expertise," stated Hock Tan, President and Chief Executive Officer of Avago. "This combination will increase the Company's scale and diversify our revenue and customer base. In addition to these powerful strategic benefits, as we integrate LSI onto the Avago platform, we expect to drive LSI's operating margins toward Avago's current levels, creating significant additional value for stockholders."  

Nuance Communications, Inc. (NASDAQ: NUAN) has announced that Jetstar has launched a new virtual assistant called "Ask Jess" which is based on Nuance Nina Web, an intelligent virtual assistant that delivers a human-like, conversational customer service experience. Customers simply type to Jess, and Jess provides the answers. Jetstar is the first airline to deploy Nuance Nina Web virtual assistant for customer service. The new Ask Jess virtual assistant draws on Nuance Nina, an intelligent virtual assistant that leverages innovative natural language understanding technology and delivers a conversational interface to web visitors which simulates human conversation. Nuance's Natural Language Understanding (NLU) technology allows applications like Ask Jess to understand a customer's intent through an interactive, text-based chat experience. By understanding what customers want, Ask Jess makes getting information on booking, baggage and seating easier than navigating pages on a Web site. Jetstar's Ask Jess virtual assistant is also fully integrated with the company's existing live chat service, delivering a seamless handover to human support when required.  

Apple Inc. (NASDAQ: AAPL) has recently acquired patent number 8,610, 726B2 for its new technology of a built-in project for a computer. Jack Purcher states this invention could create a new category of computers, as it erases the need for a display inside the actual device itself. This computer could project information on virtually any blank surface and would also carry the benefit of having no external wires besides that of a power cord. AAPL closed down .45% on Tuesday afternoon on over 6.7 million shares traded.

FinancialNewsMedia.com  is leading provider of third party publishing & news dissemination services.  If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com  for more details.  Get an edge on the market with our Premium News Alerts  that are FREE for a limited time at http://www.financialnewsmedia.com/.  Follow us on Facebook:  http://www.facebook.com/financialnewsmedia  and Twitter: http://twitter.com/FNMgroup.   Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PRESS to 545454.  (SMS alerts are free, however data rates may apply, check your wireless plan for details.)

DISCLAIMER:  FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNMG is NOT affiliated in any manner with any company mentioned herein.  FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  The companies that are discussed in this release may or may not have approved the statements made in this release.  FNMG is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  FNMG was compensated one thousand four hundred dollars for the dissemination of the news released by NXT-ID, Inc. by a non-affiliated third party.

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company:  FN Media Group, LLC
Contact email:  editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC

reade more... Résuméabuiyad

Hole Labs reinforces scientific team with two new hires before the Debut of the new technology at CES 2014

NEW YORK, 17 December 2013/PRNewswire /-hole Labs, a company security recently launched digital infrastructure, announced today that Dr. Scott Streit and Dr. Boris Kravtsov had joined the company as Chief Scientist of computing and scientific director of computer vision, respectively. The company was added to these new talents to strengthen its team of technology and further develop its assertion of identity platform.

As hole Labs puts the finishing touches to their secure identity soon-to-be-announced affirmation platform that aims to end the theft of identity and corporate piracy, Dr. Streit and Dr. Kravtsov will take an executive team consisting of computer vision, large data and expert in biometrics, with over 100 years of combined experience.

Dr. Streit is a computer scientist specializing in semantic web and relational database processing cloud computing. He has solved problems of processing for large national and international corporations to a deep knowledge of technology and pits laboratories infrastructure services. Dr. Streit has also led projects for the Government of the Apache Foundation and United States. As the computer head hole laboratories, the architect and engineer will be platform's assertion of identity new hole Labs, supervising the front - and back-end technology, as well as the Web from Amazon (AWS) and systems for enterprise customers service. Dr. Streit completed his PhD at Villanova University, where he specialized in the persistence of the semantic web.

Dr. Kravtsov also has a long career in technology, specializing in vision by computer. As Chief Scientific vision equipment company, will lead the recognition system division in the laboratories of pits, which deals with processing of images and "liveness" component in the front-end technology. Dr. Kravtsov developed previously, defence and security products and applications, including hand-recognition technology for access control and presence, as well as a family of PC applications that use face recognition technology to improve the security of the information. Dr. Kravtsov completed his doctorate at the University of Odessa, completing postgraduate courses in the field of pattern recognition.

"In the laboratories of holes, we are moving quickly with the development and launch of our new technology, and it is vital that we have the best team instead of making the kind of changes that will revolutionize the industry perspective both corporate and individual," said Hector Hoyos, veteran of the biometrics and CEO of hole Labs. "The impressive achievements of Dr. Streit and Dr. Kravtsov reflect not only his extensive knowledge of the technology, but also his dedication to the field and advancement of our company."

"I look forward working closely with both experts to bring a solution to consumers and corporations that ultimately, names and passwords obsolete," said Hoyos. "Most importantly, I am sure that the contributions of Dr. Streit and Dr. Kravtsov will change how we think about the affirmation of identity for transactions online forward".

For more information on laboratories of holes, please visit: www.hoyoslabs.com.

About hole Labs
Hole Labs is a company of security of digital infrastructure with security, computer vision and biometrics and big data experts. Hole Labs aims to develop and implement the company and the consumer identity assertion technology platforms that address conveniently and safely identity challenges claim today. Hole laboratories currently has offices in New York, Boston, Bucharest (Romania) and Beijing (China). For more information about laboratories of pits, knowledge of leadership and products, visit: www.hoyoslabs.com.

Media contacts:
Samantha Wolf / Caitlin Kasunich
The radio station KCSA Strategic Communications
swolf@KCSA.com / ckasunich@kcsa.com
212-896-1220 / 212-896-1241

SOURCE pits Labs

RELATED LINKS
http://www.hoyoslabs.com

reade more... Résuméabuiyad

Global Cancer Biomarkers Market 2012-2016 with Agilent Technologies Inc., Gen-Probe Inc. and Astellas Pharma US Inc. Dominating

DUBLIN, Ireland, December 13, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/mrb9sm/global_cancer) has announced the addition of the "Global Cancer Biomarkers Market 2012-2016" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


TechNavio's analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market.

The key vendors dominating this market space are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies Inc., Gen-Probe Inc., Hologic, Inc., and Roche Diagnostics Corp.

The other vendors mentioned in the report are Agendia BV, Ambrilia Biopharma, Astellas Pharma US Inc., Morphotek, Inc., Gen-Probe, Inc., Veridex LLC, Morphotek, Inc., Immunomedics, Inc., Clarient, Inc.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Over the years, personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. Personalized medicines are increasingly being used in targeted cancer therapies. As personalized medicines gain more importance and popularity, the demand for biomarkers is expected to increase. In the coming years, as personalized medicines become more popular, conventional approaches will automatically become obsolete.''

Further, the report reveals that one of the key challenges is the existence of poor regulatory and reimbursement systems.

For more information visit http://www.researchandmarkets.com/research/mrb9sm/global_cancer

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

SOURCE Research and Markets

reade more... Résuméabuiyad

CROS NT Ltd Announces Appointment of Andrew MacGarvey as CEO

LONDON, Dec. 12, 2013 /PRNewswire-iReach/ -- As part of the CROS NT Group global strategy, the company today announced the appointment of Andrew MacGarvey to the role of Chief Executive Officer and President from 1st January 2014. The move sees Paolo Morelli move into the role of Chairman for CROS NT allowing him to dedicate more time to PMH the holding company which oversees other life science businesses including ARITHMOS, its technology arm.

Paolo Morelli said, 'I am pleased to appoint Andrew as CEO of CROS NT, it is the culmination of a two-year plan. Andrew has overseen our expansion into the UK and USA and his combination of commercial and operational knowledge, alongside his passion for customer service, makes him the right candidate to take CROS NT forward. Andrew understands that we are a people business and I am confident he will continue to grow the company in a sustainable way. He has built a great team to support him and I look forward to watching them in the next phase of the CROS NT story.'

Morelli will devote more time to PMH, 'There are some great things happening within PMH and the time is right for me to dedicate more time to this project. I intend to work closely with ARITHMOS next year; the life sciences technology space has always excited me. Within ARITHMOS, we have the right portfolio of technologies and I want to make sure we are connecting with the market and getting these products to our customers'.

Andrew MacGarvey said 'It was a privilege to be asked to take on the role of CEO of CROS NT and I was delighted to accept the position. Paolo has built a company that reflects his philosophy. Every member of the team is highly valued, as are each and every one of our customers. My job is to continue to build the business, while ensuring we protect the unique way we work, and I am looking forward to the challenge. We are seeing growing demand for our offering, specialist statistical and data services delivered through a global organisation. Following our activities this year we are now able to deliver these services across the pharmaceutical, biotechnology and medical device sectors.'

MacGarvey brings over 15 years' experience in the sector to the role. He has worked at a number of CROs in senior positions covering both the commercial and operational areas. He has lived and worked in both the USA and the UK giving him an international perspective on the sector.

About CROS NT

In its 21st year, CROS NT is a global Contract Research Organization (CRO) specialized in clinical data services. With over 800 studies completed in a variety of therapeutic areas and indications, CROS NT has remained focused on biometrics including statistical consultancy, programming and analysis, clinical data management, medical writing, pharmacovigilance and life science technology solutions. We collect, integrate and analyze data from various sources and uses processes and technology to ensure excellent project governance, reporting and traceability. 

Media Contact: Mary Wieder, CROS NT Ltd, +44 (0)1908 488822, mary.wieder@crosnt.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CROS NT

reade more... Résuméabuiyad

Kurt H. Becker Named a Fellow of the National Academy of Inventors

BROOKLYN, N.Y., Dec. 10, 2013 /PRNewswire/ -- Kurt H. Becker, the associate provost for research and technology initiatives and a professor at the Polytechnic Institute of New York University (NYU-Poly), has been named a fellow of the National Academy of Inventors (NAI). 

Becker was chosen by the NAI for his spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. His pioneering work with atmospheric-pressure cold plasmas paved the way for new, more effective methods of sterilizing medical instruments and other biomedical and environmental applications, and he holds numerous patents on his discoveries.

Since joining NYU-Poly in 2007, Becker has been instrumental in helping the Institute translate its mission of Invention, Innovation, and Entrepreneurship (i2e) into action. He is the academic lead for PowerBridgeNY, a New York State Energy Research and Development Authority (NYSERDA)-sponsored proof of concept center, which will leverage clean-energy innovations emerging from institutional research labs to create more and stronger businesses in New York State. He is also the NYU-Poly academic lead in the Northeastern Regional Node of the National Science Foundation's Innovation Corps (I-Corps), a joint program with CUNY (lead) and Columbia University that prepares academic researchers to become entrepreneurs and speeds the commercialization of their research.

NYU-Poly is home to some of the top university business incubators in the world, and Becker serves as a valuable liaison between faculty members and the incubators' staff and companies. Additionally, he was one of the creators of the school's popular Inno/Vention competition--now in its seventh year--which challenges NYU–Poly and NYU students from across the globe to prototype and develop commercially viable ideas for real-world problems.  

NYU-Poly President Katepalli R. Sreenivasan said, "As an NAI Fellow, Kurt Becker takes his place among an august company. We are proud that the organization has recognized, as we do at New York University, that Dr. Becker exemplifies the spirit of innovation and invention. We consider him an enormous credit to the Institute and are grateful for all his work on our behalf."

The 143 innovators elected to NAI Fellow status represent 94 universities and governmental and non-profit research institutes. Together, they hold more than 5,600 U.S. patents. Included in the 2013 class are 26 presidents and senior leadership of research universities and non-profit research institutes, 69 members of the National Academies, five inductees of the National Inventors Hall of Fame, six recipients of the U.S. National Medal of Technology and Innovation, two recipients of the U.S. National Medal of Science, and nine Nobel laureates.

The NAI Fellows will be inducted by Deputy U.S. Commissioner for Patents Andy Faile during the NAI's 3rd Annual Conference on Mar. 7, 2014, in Alexandria, Va., at the headquarters of the United States Patent and Trademark Office.

Becker is a professor in two NYU-Poly academic departments, Applied Physics and of Mechanical and Aerospace Engineering. He holds master's and doctoral degrees in physics from Germany's Universitaet des Saarlandes. He is an honorary professor at the Leopold-Franzens Universitaet, in Innsbruck, Austria. His many other honors include the Dr. Eduard-Martin Prize for Excellence in Research, a fellowship in the American Physical Society, and the 2007 Thomas Alva Edison Patent Award, and the SASP Erwin Schroedinger medal of the University of Innsbruck.

The Polytechnic Institute of New York University (formerly the Brooklyn Polytechnic Institute and the Polytechnic University, now widely known as NYU-Poly) is an affiliated institute of New York University, soon to be its School of Engineering. NYU-Poly, founded in 1854, is the nation's second-oldest private engineering school. It is presently a comprehensive school of education and research in engineering and applied sciences, rooted in a 159-year tradition of invention, innovation and entrepreneurship. It remains on the cutting edge of technology, innovatively extending the benefits of science, engineering, management and liberal studies to critical real-world opportunities and challenges, especially those linked to urban systems, health and wellness, and the global information economy. In addition to its programs on the main campus in New York City at MetroTech Center in downtown Brooklyn, it offers programs around the globe remotely through NYUe-Poly. NYU-Poly is closely connected to engineering in NYU Abu Dhabi and NYU Shanghai and to the NYU Center for Urban Science and Progress (CUSP) also at MetroTech, while operating two incubators in downtown Manhattan and Brooklyn. For more information, visit www.poly.edu.

SOURCE Polytechnic Institute of New York University

RELATED LINKS
http://www.poly.edu

reade more... Résuméabuiyad

SourceMedical Announces Hiring of Clinical Expert for ASC Division

Ann Geier has been named VP-Clinical Informatics by Source Medical Solutions, Inc. (PRNewsFoto/SourceMedical)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";BIRMINGHAM, Ala., Dec. 10, 2013 /PRNewswire-iReach/ -- Source Medical Solutions, Inc., the nation's leading provider of specialized software and billing services to outpatient surgery centers and specialty hospitals, announced today it has hired Ann Geier to the position of Vice President-Clinical Informatics within its Surgery division. In this role, Ms. Geier will provide product development insight that draws upon her 30-plus years of experience in the ASC industry.

(Photo: http://photos.prnewswire.com/prnh/20131210/MN30283)

Over the course of her career, Ms. Geier has been responsible for total financial and clinical operations in nationally based management companies and freestanding surgery centers. A recognized presenter and thought leader, she teaches in the AORN Ambulatory Boot Camp and speaks at national meetings on topics such as Supply Chain Management, Human Resources, Case Costing, QAPI, Credentialing and Peer Review, and Staffing. Ms. Geier's clinical background is the operating room, where she has been a scrub nurse, circulator, educator, and director. She has served on the ASC Quality Collaborations Expert Group since its inception in 2006.

"I've worked with Ann for several years, and because of my respect for her operational and clinical skills, I am confident that she will bring valuable expertise to SourceMedical," says Patrick Doyle, SourceMedical's EVP-Sales and Marketing.

"The addition of Ann Geier to our leadership team is another demonstration of our commitment to delivering the best products and services to the ASC market," says Ralph Riccardi, CEO of SourceMedical. "Her understanding of the challenges faced by administrators and owners, and the input she will provide as we deliver solutions, are fully aligned with our strategic vision."

"I am delighted to join the SourceMedical team, with its deep commitment to solutions that help surgery centers run more efficiently and enable a higher quality of patient care," Ms. Geier says.

***

About SourceMedical

SourceMedical is the largest provider of outpatient information solutions and revenue cycle management services for ambulatory surgery centers, specialty hospitals, and rehabilitation clinics nationwide. With 30 years of real-world experience, more than 5,000 satisfied customers, and the confidence of more than 250 consultants and management companies, SourceMedical offers the broadest range of solutions and enhancements available to the industry. The company's unique end-to-end systems improve operational efficiency and cash flow while enabling healthcare facilities to capture, exchange, and analyze data to deliver a higher standard of patient care. For more information, please visit www.sourcemed.net.

                                                            ###

Press contact information:

Kathleen M. Joyce

kathleen.joyce@sourcemed.net or 203-284-7596

Media Contact: Kathleen Joyce, SourceMedical, 203-284-7596, kathleen.joyce@sourcemed.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE SourceMedical

RELATED LINKS
http://www.sourcemed.net

reade more... Résuméabuiyad

DigitalPersona FingerJet Recognition Engine Top Performer in Recent MINEX Testing

REDWOOD CITY, Calif., Dec. 11, 2013 /PRNewswire/ -- DigitalPersona, Inc., a trusted partner for biometric identity verification solutions, today announced that the DigitalPersona® FingerJet® Recognition Engine matching elements have been certified by the National Institute of Standards and Technology (NIST) and the MINEX (Minutia Exchange) testing program to meet the United States Government's Personal Identity Verification (PIV) standards.  The DigitalPersona FingerJet Recognition Engine feature extractor had been certified by NIST in earlier testing. These two certifications assure that fingerprint templates obtained by the DigitalPersona FingerJet Recognition Engine are interoperable across other certified extraction and matching engines.

Ensuring interoperability of fingerprint technology components has become essential as the use of fingerprints for strong authentication and identity is more widespread.  The MINEX test confirms matching performance of standards-based (INCITS 378) fingerprint templates when tested across vendors and validates performance of fingerprint engines using tens of thousands of fingerprint images in government databases. 

As of December 2013, 68 vendors have submitted fingerprint feature extraction and/or matching engines for testing.  The result of testing has confirmed that the DigitalPersona FingerJet Recognition Engine is in the top 10% of all tested engines, both for absolute performance and mean and median accuracy when interoperating with other compliant engines. 

"A unique property of our engine is its use in low-cost, embedded processors without compromise in accuracy or responsiveness," said Vance Bjorn, CTO and vice president of corporate development at DigitalPersona. "This has enabled DigitalPersona's engine to be one of the most widely deployed engines for fingerprint authentication. More than 200M people rely on DigitalPersona's fingerprint technology and products in commercial authentication applications."

The MINEX results can be found here.

About DigitalPersona

DigitalPersona offers the world's broadest portfolio of biometrics-based identity verification solutions. Applications range from highly secure banking environments and complex government identity programs to point-of-sale retail systems. Our solutions verify the identity of more than 200 million authorized users worldwide and significantly reduce the risk of fraud, theft and unauthorized access. Offerings for end-users and system integrators include industry-specific software applications, complete SDKs and a full range of optical, silicon, touch, swipe and embedded readers.   For more information call +1 650.474.4000, send an email to pr@digitalpersona.com or visit www.digitalpersona.com.

© 2013 DigitalPersona, Inc. All rights reserved. DigitalPersona and FingerJet are trademarks of DigitalPersona, Inc. registered in the United States and other countries. All other trademarks are the property of their respective owners.  This information should not be relied upon as legal advice.  This information does not constitute an offer to sell or a commitment of present or future availability of any products or features.  Availability of any DigitalPersona products is subject to change at DigitalPersona's sole discretion.  DigitalPersona specifically disclaims all warranties of any kind, express or implied.  Users must take full responsibility for their application of any products or compliance with any national, state or local legal or regulatory requirements of any kind.

SOURCE DigitalPersona, Inc

RELATED LINKS
http://www.digitalpersona.com

reade more... Résuméabuiyad

KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody

KaloBios logo. (PRNewsFoto/KaloBios)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";SOUTH SAN FRANCISCO, Calif., Dec. 10, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced preliminary results of an ongoing multi-center Phase 1 study of KB004, an anti-EphA3 monoclonal antibody (mAb), which the company is developing as a treatment for hematologic malignancies. Forty-four patients with refractory disease or who were unfit for chemotherapy have been enrolled in the dose escalation portion of the study.  The experimental patient-targeted therapeutic has been well tolerated, with initial evidence of clinical activity.

(Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO)

Preliminary results of the study were presented yesterday by lead investigator, Jeffrey E. Lancet, M.D. of the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida at the 55th American Society of Hematology Annual Meeting and Exhibition (ASH), held this week in New Orleans, Louisiana.

"We are encouraged by the results seen with KB004 to date, which has been well-tolerated at doses up to 190 mg, with mild to moderate transient infusion reactions the most common toxicity," said Dr. Lancet. "There are some signs of activity as well, including a patient with relapsed acute myeloid leukemia (AML) who had sustained remission for over 1 year."

Escalating doses of KB004 were administered as a 1 or 2 hour infusion on days 1, 8, and 15 of a 21 day cycle at incremental doses of 20, 40, 70, 100, 140, 190 and 250 mg and will thereafter increase at 33% increments up to a planned maximum of 700 mg. The primary study objective is to determine a maximum tolerated dose, which has not yet been reached. Secondary objectives included evaluation of pharmacokinetics, immunogenicity and clinical activity. The investigators also evaluated EphA3 expression on tumor, stromal and endothelial cells.

Nestor Molfino, M.D., MSc, KaloBios' Chief Medical Officer, commented, "KB004 targets EphA3, which is expressed in adults on hematologic malignancies and solid tumors, including tumor stem cells, but not on normal blood or bone marrow stem cells. The targeted nature of this antibody may represent a promising approach to selectively treat patients with hematologic malignancies. As we have not yet reached a maximum tolerated dose, we will continue to study higher doses of KB004 as part of this ongoing trial to determine an optimum high-end dose for the Phase 2 expansion portion of the study in patients with AML or myelodysplastic syndrome (MDS) which is expected to begin by the end of the year."

The poster presented at ASH can be viewed on the KaloBios website.

About KaloBios

KaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies designed to treat severe life-threatening or debilitating diseases for which there is an unmet medical need, with a clinical focus on severe respiratory diseases and cancer.

Currently, KaloBios has three drug development programs:

KB003, an anti-GM-CSF mAb with potential to treat inflammatory diseases, being developed for the treatment of severe asthma. Enrollment of 160 patients has been completed in a Phase 2 study in the United States, Europe and Australia. KB001-A, an anti-PcrV mAb fragment, partnered exclusively with Sanofi Pasteur and is being developed for the prevention and treatment of Pseudomonas aeruginosa (Pa) infection. KaloBios has retained rights for the cystic fibrosis indication and is conducting a 180 patient Phase 2 study in CF subjects with chronic Pa lung infection in the United States.  KaloBios has received Orphan Drug designation from both the U.S. FDA and the European Medicines Agency for KB001-A for the treatment of Pa lung infection in CF patients. Sanofi is pursuing a ventilator-associated pneumonia prevention indication in the intensive care setting, an indication which has received U.S. FDA Fast Track Designation. KB004, an anti-EphA3 mAb, has potential in treating hematologic malignancies and solid tumors. KaloBios is currently testing this drug in a Phase 1 study in subjects with hematologic malignancies. All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered® technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Forward Looking Statements
This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including: the statements under the heading "Anticipated Upcoming Milestones"; and statements regarding the company's clinical development of KB001-A, KB003 and KB004. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the company's limited cash reserves and its ability to obtain additional capital on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that the company has initiated or plans to initiate; the company's dependence on Sanofi Pasteur for the development and commercialization of KB001-A; the company's ability to successfully complete further development of its programs; the uncertainties inherent in clinical testing; the timing, cost and uncertainty of obtaining regulatory approvals; the company's ability to protect the company's intellectual property; competition; changes in the regulatory landscape or the imposition of regulations that affect the company's products; and other factors listed under "Risk Factors" in the company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 1, 2013, the quarterly reports on Form 10-Q filed on May 14, August 19, and November 12, 2013, and the company's other filings with the Securities and Exchange Commission.

All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The company has no obligation, and expressly disclaims any obligation to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, visit http://www.kalobios.com.

Herb Cross

Chief Financial Officer

KaloBios Pharmaceuticals, Inc.

(650) 243-3114

ir@kalobios.com

SOURCE KaloBios Pharmaceuticals, Inc.

RELATED LINKS
http://www.kalobios.com

reade more... Résuméabuiyad

SourceMedical Announces Hiring of Clinical Expert for ASC Division

Ann Geier has been named VP-Clinical Informatics by Source Medical Solutions, Inc. (PRNewsFoto/SourceMedical)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";BIRMINGHAM, Ala., Dec. 10, 2013 /PRNewswire-iReach/ -- Source Medical Solutions, Inc., the nation's leading provider of specialized software and billing services to outpatient surgery centers and specialty hospitals, announced today it has hired Ann Geier to the position of Vice President-Clinical Informatics within its Surgery division. In this role, Ms. Geier will provide product development insight that draws upon her 30-plus years of experience in the ASC industry.

(Photo: http://photos.prnewswire.com/prnh/20131210/MN30283)

Over the course of her career, Ms. Geier has been responsible for total financial and clinical operations in nationally based management companies and freestanding surgery centers. A recognized presenter and thought leader, she teaches in the AORN Ambulatory Boot Camp and speaks at national meetings on topics such as Supply Chain Management, Human Resources, Case Costing, QAPI, Credentialing and Peer Review, and Staffing. Ms. Geier's clinical background is the operating room, where she has been a scrub nurse, circulator, educator, and director. She has served on the ASC Quality Collaborations Expert Group since its inception in 2006.

"I've worked with Ann for several years, and because of my respect for her operational and clinical skills, I am confident that she will bring valuable expertise to SourceMedical," says Patrick Doyle, SourceMedical's EVP-Sales and Marketing.

"The addition of Ann Geier to our leadership team is another demonstration of our commitment to delivering the best products and services to the ASC market," says Ralph Riccardi, CEO of SourceMedical. "Her understanding of the challenges faced by administrators and owners, and the input she will provide as we deliver solutions, are fully aligned with our strategic vision."

"I am delighted to join the SourceMedical team, with its deep commitment to solutions that help surgery centers run more efficiently and enable a higher quality of patient care," Ms. Geier says.

***

About SourceMedical

SourceMedical is the largest provider of outpatient information solutions and revenue cycle management services for ambulatory surgery centers, specialty hospitals, and rehabilitation clinics nationwide. With 30 years of real-world experience, more than 5,000 satisfied customers, and the confidence of more than 250 consultants and management companies, SourceMedical offers the broadest range of solutions and enhancements available to the industry. The company's unique end-to-end systems improve operational efficiency and cash flow while enabling healthcare facilities to capture, exchange, and analyze data to deliver a higher standard of patient care. For more information, please visit www.sourcemed.net.

                                                            ###

Press contact information:

Kathleen M. Joyce

kathleen.joyce@sourcemed.net or 203-284-7596

Media Contact: Kathleen Joyce, SourceMedical, 203-284-7596, kathleen.joyce@sourcemed.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE SourceMedical

RELATED LINKS
http://www.sourcemed.net

reade more... Résuméabuiyad